Table 1.
Clinical and laboratory features of 120 patients with primary biliary cirrhosis (PBC) participated in the study.
| Feature | PBC (n = 120) |
|---|---|
| Age (median; range) | 56 (22–83) |
| Gender (M/F) | 11/109 |
| AMA (pos/neg) | 101/19 |
| *Anti-sp100 (pos/neg) | 27/92 |
| *Anti-gp210 (pos/neg) | 15/104 |
| **Cirrhosis (yes/no) (%) | 33/85 (28/72%) |
| ALT (median; range) IU/L (Normal: 3–30) | 90 (10–987) |
| ALP (median; range ), IU/L (Normal: 40–120) | 304 (47–2264) |
| GGT (median; range), IU/L (Normal: 3–30) | 311 (11–2608) |
| Bilirubin (median; range), mg/dL (Normal: 0.2–1.0) | 1.9 (0.2–25.1) |
| Albumin (median; range), g/dL (Normal: 3.8–4.4) | 3.9 (2.3–5.8) |
| INR (median; range) (Normal: 0.8–1.2) | 1.04 (0.8–2.3) |
| Cholesterol (median; range ), mg/dL (Normal < 200) | 249 (108–1096) |
| Triglycerides (median; range), mg/dL (Normal < 150) | 124 (42–448) |
*In 1 patient these tests were not done; **in 2 patients fibrosis status was not determined.
M: male; F: female; AMA: antimitochondrial antibody; Pos: positive; Neg: negative.